Markets

Fourth quarter GDP rose by 4% from a year ago, according to China’s National Bureau of Statistics, faster than the 3.6% increase forecast by a Reuters poll.

Numbers from China’s National Bureau of Statistics showed the Chinese economy grew by 8.1% in 2021, slightly below the market’s expectation.

TipRanks analyst ranking service pinpoints Wall Street’s best-performing stocks, like Dick’s Sporting Goods and Microsoft.

Cannabis ETF manager Tim Seymour shares his 2022 forecast for the rapidly growing industry as U.S. legalization hangs in the balance.

In what likely will just a few months’ time, the Federal Reserve will look a lot different.

Markets finished the week lower as investors attempted to “price in” the potential for as many as four Fed rate hikes by year end.

The market’s focus turns to fourth-quarter earnings season, which is expected to be a period of much stronger profit growth for some cyclical sectors.

Russia is amassing troops on its border with Ukraine. The U.S. and its allies plan to use economic sanctions to deter an invasion. Here’s how they work.

Wells Fargo (WFC) reported better-than-expected fourth-quarter 2021 results before the opening bell Friday.

The fourth biggest U.S. bank by assets posted quarterly revenue that exceeded analysts’ expectations.

Citigroup shares were under pressure Friday after the banking giant reported a steep profit drop for the fourth quarter.

Sens. Bernie Sanders, Elizabeth Warren and Tammy Baldwin pressed BlackRock CEO Larry Fink to intervene in a coal miners’ strike.

U.S. Treasury yields climbed on Friday, as investors remained focused on hawkish comments from Federal Reserve officials.

President Joe Biden will nominate Sarah Bloom Raskin to be the Federal Reserve’s next vice chair for supervision, a powerful regulatory role.

JPMorgan and Citigroup slid after their earnings reports, weighing on the stock market.

Turkey’s lira lost 44% of its value in 2021, due in large part to a refusal by the president to raise interest rates to rein in inflation.

Jim’s thoughts on the big morning news and calls.

We question the magnitude of Eli Lilly’s decline for a few reasons.

Jim’s thoughts on the Fed, Meta, Ford and more…

While we do not violate our overall cost basis lightly, we do believe the weakness thus far in 2022 is presenting an opportunity that we want to take advantage.